Key result
Continuous regional intra-aortic infusion of chemotherapy yielded a 26.4% objective response rate compared to 0% with intravenous administration in patients with inoperable lung cancer.
Why the study?
Does continuous regional intra-aortic infusion of fluorouracil and cyclophosphamide improve objective response and survival time in patients with inoperable or nonresectable lung cancer compared to intravenous administration?
Cohort (n=147)
Does continuous regional intra-aortic infusion of fluorouracil and cyclophosphamide improve objective response and survival time in patients with inoperable or nonresectable lung cancer compared to intravenous administration?
Continuous regional intra-aortic infusion of chemotherapy may improve survival and objective response duration in patients with inoperable lung cancer compared to intravenous administration.
Answers are grounded in this paper and cite their sources.
Intra-aortic infusion was associated with higher response rates in inoperable lung cancer; hypothesis-generating and should not change practice without randomized confirmation.
Over a period of four years, 91 patients with inoperable or nonresectable lung cancer (55 bronchogenic and 36 metastatic) were treated by the continuous regional intra-aortic infusion of fluorouracil and cyclophosphamide, or both, for the purpose of increasing and prolonging the concentration of these agents in tumor-bearing areas supplied by the bronchial arteries. Twelve of the patients with bronchogenic cancer showed an objective response rate of 12.4 months' duration with an average survival time of 13.4 months. In the metastatic group, the cancers of 12 patients had an average objective regression of 12.5 months' duration with an average survival time of 14.5 months. A comparable retrospective study of the intravenous method of administration demonstrated no objective response (by our criteria) in 49 cases of bronchogenic and seven cases of metastatic lung cancer. Average survival time was 4.2 and 4.4 months, respectively.
No takes yet. Share an insight, caveat, or question.
Herman A. Freckman (1966) conducted a cohort in Inoperable or nonresectable lung cancer (n=147). Continuous regional intra-aortic infusion of fluorouracil and/or cyclophosphamide vs. Intravenous method of administration was evaluated on Objective response. Continuous regional intra-aortic infusion of chemotherapy yielded a 26.4% objective response rate compared to 0% with intravenous administration in patients with inoperable lung cancer.
Synapse has enriched 10 related papers. Consider them for comparative context: